MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 11..20 of 162 - per page Previous page Next page
Order by
Adhesive patch containing and delivering essential and balsamic oils for the symptomatic treatment of the common cold and nasal congestion More
A novel selective antimicrobial peptide based on human LL-37 by D-amino acid incorporation. More
The inactivation approach presented in this technology provides for a safe, non-infectious composition for vaccination against the corresponding agent. More
A new veterinary medicinal composition designed to maintain the oxygenic consumption, to restore hydric, electrolytic and energetic status, as well as the blood pH in affected mammals. More
This technology overcomes the amount of time required to culture and identify pathogens, using standard collection methods, is able to identify over 98% of relevant pathogens, and is a fully automated process More
Novel use of amine-borane compounds for the treatment of medical conditions associated with microorganisms. These novel amine-borane compounds are an answer to the massive search being conducted for novel antimicrobial agents to deal with the... More
Biocompatible and biodegradable nanoparticles designed to encapsulate drug allowing for its absorption and delivery More
Third generation long-acting, site-specific PEGylated interferon-alpha, having one predominate positional isomer, offering a longer half-life and so requiring a less frequent dosage regime. The new design also gives improved production yields. More
Azithromycin Oral Suspension, 2 g/vial More
Specific and sensitive microarray and multiplex assay for the simultaneous detection and discrimination of HCV, HBV, and HIV-1, which include both RNA and DNA genomes. More
Displaying 11..20 of 162 - per page Previous page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us